Key TakeawaysEli Lilly and Novo Nordisk shares rose Tuesday after the Biden administration proposed expanding coverage of the companies' weight-loss drugs in government-backed healthcare plans.The proposal recommended drugs like Ozempic and Mounjaro be covered under Medicare and Medicaid, making them more accessible to millions of new patients.The White House said the changes could also lower costs of the drugs. Eli Lilly (LLY) and Novo Nordisk (NVO) shares rose Tuesday after the Biden administration propos ...